Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: A novel phosphoramide compound, DCZ0805, shows potent anti-myeloma activity via the NF-κB pathway

Fig. 1

Cytotoxicity of DCZ0805 towards human MM cell lines. a Chemical structure of DCZ0805. b MM cell lines (H929, ARP-1, U266, RPMI-8226 and H929R) were treated with DCZ0805 (0–32 µM) for 48 h, followed by assessment for cell viability. c H929 and ARP-1 cells were treated with DCZ0805 (0–32 µM) and processed at the indicated times, then assessed the cell viability. d Micrographs (original magnification, × 50) of proliferation via EdU assay (nuclear staining with DAPI, blue; proliferating cells stained with EdU, red)

Back to article page